Skip to main content

OpenAI Bets Big: $2 Billion Deal with Cerebras Could Secure 10% Stake

OpenAI's Strategic Play in Semiconductor Space

In a move that underscores the critical importance of computing power in the AI arms race, OpenAI has inked a landmark agreement with Cerebras Systems. The artificial intelligence leader has committed to spending over $20 billion on computing services powered by Cerebras chips over the next three years, with the potential to acquire nearly 10% of the semiconductor company.

The Deal Breakdown

This isn't the first rodeo for these two tech players. Back in January, OpenAI signed a $10 billion contract to purchase up to 750 megawatts of computing capacity from Cerebras. The new agreement significantly raises the stakes, with OpenAI pledging an additional $1 billion to help Cerebras construct specialized data centers. All told, the partnership could funnel as much as $30 billion into Cerebras' coffers by 2029.

"What makes this deal particularly interesting," observes tech analyst Mark Henderson, "is the equity component. OpenAI isn't just buying services—they're buying influence. A 10% stake would give them serious skin in the game as Cerebras prepares for its IPO."

Cerebras' Path to Going Public

The timing couldn't be better for Cerebras. The California-based chip designer, known for its revolutionary wafer-scale engine technology, is gearing up for a second-quarter public offering. Next month's planned $3 billion funding round could value the company at $35 billion—a staggering figure for a firm founded just nine years ago in 2015.

Sam Altman, OpenAI's CEO and an early Cerebras investor, clearly sees strategic value in the relationship. The deal reflects the explosive demand for inference computing power—the kind needed to run AI applications after they've been trained—as businesses race to deploy generative AI solutions.

Why This Matters for AI's Future

This partnership signals several key industry trends:

  • The compute crunch is real: As AI models grow more sophisticated, so do their hardware demands. Companies are scrambling to secure long-term computing capacity.
  • Vertical integration is accelerating: AI leaders aren't content to just develop software—they're increasingly investing in the hardware stack beneath it.
  • The semiconductor landscape is shifting: Traditional chipmakers now face serious competition from specialized AI hardware startups like Cerebras.

With Cerebras expected to disclose more deal details this Friday, all eyes will be on how this partnership reshapes the AI infrastructure landscape.

Key Points

  • OpenAI commits to $20+ billion in Cerebras services over three years
  • Additional $1 billion investment for Cerebras data center development
  • Potential equity stake could reach 10% of the company
  • Deal supports Cerebras' plans for Q2 IPO and $3 billion funding round
  • Highlights growing industry demand for AI inference computing power

Enjoyed this article?

Subscribe to our newsletter for the latest AI news, product reviews, and project recommendations delivered to your inbox weekly.

Weekly digestFree foreverUnsubscribe anytime

Related Articles

OpenAI's GPT-Rosalind: AI's Big Leap into Drug Discovery
News

OpenAI's GPT-Rosalind: AI's Big Leap into Drug Discovery

OpenAI has unveiled GPT-Rosalind, a specialized AI model named after DNA pioneer Rosalind Franklin, designed to revolutionize life sciences research. Currently in limited release with partners like Amgen and Moderna, this tool helps scientists analyze biochemical data, generate hypotheses, and accelerate drug development. While experts debate AI's role in replacing human researchers, the announcement already sent ripples through biotech markets.

April 17, 2026
AI in healthcareDrug discoveryOpenAI
News

ChatGPT's Gender Milestone: Women Now Make Up Majority of Users

In a significant shift, women now account for over 50% of ChatGPT users, marking a dramatic change since the platform's male-dominated early days. The AI tool approaches 1 billion total users worldwide, with nearly half a billion active female users weekly. Meanwhile, OpenAI's computing power expansion continues at breakneck speed, positioning the company for future AI dominance.

April 17, 2026
ChatGPTAI trendsTechnology demographics
News

Cerebras and OpenAI Seal $2 Billion AI Chip Deal, Eye $35 Billion IPO

AI chip innovator Cerebras has inked a massive $2 billion, three-year deal with OpenAI, marking one of the largest partnerships in the semiconductor industry. As part of the agreement, OpenAI will invest $1 billion to help develop Cerebras' data center systems while securing a potential 10% stake in the company. Meanwhile, Cerebras is gearing up for a blockbuster IPO that could value the company at over $35 billion, signaling heated competition in the AI hardware space.

April 17, 2026
AI ChipsSemiconductorsTech IPO
ChatGPT Hits 1 Billion Users as Women Take the Lead
News

ChatGPT Hits 1 Billion Users as Women Take the Lead

OpenAI's latest data reveals a major shift in ChatGPT's user demographics. For the first time, women now make up over 50% of the platform's weekly active users, which are approaching 1 billion globally. This marks a dramatic change from 2022 when male users dominated at 80%. The AI tool's growing appeal across genders comes alongside massive computing power expansions that promise even better service in the future.

April 17, 2026
ChatGPTAI trendsTechnology demographics
OpenAI Unveils GPT-Rosalind: AI That Could Revolutionize Drug Discovery
News

OpenAI Unveils GPT-Rosalind: AI That Could Revolutionize Drug Discovery

OpenAI has taken a bold step into life sciences with GPT-Rosalind, a specialized AI model named after DNA pioneer Rosalind Franklin. Unlike general chatbots, this tool can analyze protein structures, predict gene functions, and suggest experimental pathways—outperforming human experts in some tests. Currently available only to select biotech firms, it promises to accelerate drug development while raising important questions about AI's role in scientific discovery.

April 17, 2026
AI-in-biotechdrug-discoveryOpenAI
OpenAI's Codex Gets Smarter: Now Controls Your Mac Like a Pro
News

OpenAI's Codex Gets Smarter: Now Controls Your Mac Like a Pro

OpenAI just gave its Codex AI assistant some serious upgrades. The tool can now control Mac applications independently, run multiple tasks simultaneously, and remember your workflow preferences for days. Imagine having a digital assistant that clicks, types, and browses for you - that's what Codex delivers with this update. Developers will particularly love how it seamlessly picks up paused projects and even suggests next steps.

April 17, 2026
AI ProgrammingMac AutomationOpenAI